Taisho Pharmaceutical Holdings Co. Ltd. engages in the management of its group companies which are engaged in the manufacture and sale of over-the-counter (OTC) drugs, food, and miscellaneous goods. It operates through the Self-Medication and Prescription segments. The Self-Medication segment conducts research and development (R&D), manufacture, and sale of OTC drugs, quasi-drugs, food, and general medical and hygiene supplies; and deals with the lease of real estate properties and management of hotels. The Prescription segment handles R&D, manufacture, and sale of ethical drugs. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Taisho Pharmaceutical Holdings Co. Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Taisho Pharmaceutical Holdings Co. Ltd. market cap is $4.65B.
What is the 52-week high for Taisho Pharmaceutical Holdings Co. Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Taisho Pharmaceutical Holdings Co. Ltd. 52 week high is $60.00 as of September 06, 2025.
What is the 52-week low for Taisho Pharmaceutical Holdings Co. Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Taisho Pharmaceutical Holdings Co. Ltd. 52 week low is $38.00 as of September 06, 2025.
What is Taisho Pharmaceutical Holdings Co. Ltd. stock price today?
Taisho Pharmaceutical Holdings Co. Ltd. stock price today is $59.00.
What was Taisho Pharmaceutical Holdings Co. Ltd. stock price yesterday?
Taisho Pharmaceutical Holdings Co. Ltd. stock price yesterday was $59.23.
What is the PE ratio of Taisho Pharmaceutical Holdings Co. Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Taisho Pharmaceutical Holdings Co. Ltd.’s P/E ratio is 83.19.
What is the Price-to-Book ratio of Taisho Pharmaceutical Holdings Co. Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Taisho Pharmaceutical Holdings Co. Ltd. P/B ratio is 0.8194.
What is the 50-day moving average of Taisho Pharmaceutical Holdings Co. Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Taisho Pharmaceutical Holdings Co. Ltd. 50-day moving average is $59.00.